The following is true of selegiline:
A. It does not exert antiparkinsonian action
unless combined with levodopa
B. It overcomes the ‘on-off ’ effect in levodopa
treated advanced parkinsonian patients
C. It retards the progression of Parkinson's
disease
D. At doses used in parkinsonism it does not
interfere with peripheral metabolism of
dietary amines
A. It does not exert antiparkinsonian action
unless combined with levodopa
B. It overcomes the ‘on-off ’ effect in levodopa
treated advanced parkinsonian patients
C. It retards the progression of Parkinson's
disease
D. At doses used in parkinsonism it does not
interfere with peripheral metabolism of
dietary amines